TheraRadar
← Back
Data updated: Mar 29, 2026

LUOXIN AUROVITAS

Respiratory
Generics

LUOXIN AUROVITAS is a generic drug manufacturer focused on Respiratory.

2016
Since
5
Drugs
-
Trials
14
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Respiratory 100%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...